FindTrial
Sign In

18F-αvβ6-BP

DRUG2 trials

Sponsors

Julie L. Sutcliffe, Ph.D, University of California, Davis

Conditions

Breast CarcinomaCOVID-19Colorectal CarcinomaLung CarcinomaMetastatic Malignant Neoplasm in the BreastMetastatic Malignant Neoplasm in the ColonMetastatic Malignant Neoplasm in the LungMetastatic Malignant Neoplasm in the Rectum

Early Phase 1

First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide
Active, not recruitingNCT03164486
Julie L. Sutcliffe, Ph.DBreast Carcinoma, Colorectal Carcinoma, Lung Carcinoma +5
Start: 2016-11-01End: 2026-12-01Target: 27Updated: 2026-02-27
PET/CT Imaging in COVID-19 Patients
CompletedNCT04376593
University of California, DavisCOVID-19, SARS-CoV-2 Infection
Start: 2020-05-01End: 2026-02-23Updated: 2026-03-10

Related Papers

Abstract IA-13: Molecularly targeted imaging and treatment via the integrin αvβ6
Cancer Research2020-11-131 citations